Saturday, October 24, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· March 4, 2026

DeepHealth Unveils Industry’s Most Comprehensive Portfolio of Native Clinical AI Solutions at ECR 2026

View original at finance.yahoo.com
DeepHealth Unveils Industry’s Most Comprehensive Portfolio of Native Clinical AI Solutions at ECR 2026 RadNet, Inc…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Neuro Suite demonstrated 92% sensitivity in early identification of hippocampal atrophy associated with mild cognitive disorders and Alzheimer's disease

    80% confidence
  • Breast Suite AI-powered risk assessment tool predicts patient's near-term cancer risk with 2x greater accuracy than traditional risk models

    80% confidence
  • DeepHealth's unified platform has fundamentally changed how we serve our patients. From prostate and lung cancer screening to the assessment of neurodegenerative disease, we now have one cohesive, AI-powered ecosystem that gives our radiologists the clinical confidence to detect disease earlier and the workflow efficiency to do it at scale

    80% confidence
  • These solutions transform imaging pathways, enabling healthcare systems to move from reactive treatment to proactive intervention while addressing the realities of diverse European markets, to improve patient outcomes

    80% confidence
  • Thyroid Suite deployment demonstrated ability to reduce scan slot time by up to 30% at RadNet sites

    80% confidence
  • As European nations scale their screening ambitions and confront rising workload pressures, our integrated portfolio is designed to stage shift disease, empower diagnostic excellence and expand patient access, thereby driving precision care

    80% confidence
  • Radiologists accepted AI-based measurements and characterization without correction in greater than 94% of thyroid imaging cases across 240+ RadNet sites

    80% confidence
  • With Gleamer integration, DeepHealth now offers the most comprehensive radiology AI portfolio in the market

    80% confidence
  • DeepHealth's expanded portfolio delivers the industry's most comprehensive portfolio of native clinical AI solutions across all core imaging modalities

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise Software Races to Govern and Consolidate Around Agentic AI
Enterprise software vendors are repositioning around autonomous AI agents. Salesforce is acquiring Braze, ServiceNow is launching agent governance tools (AI Passport, Super Intelligence Control Tower), SAP is pushing its 'Autonomous Enterprise', and Zeta is launching AthenaOS and its own inference model. Palantir is embedding itself in banking, aviation and sovereign AI infrastructure through partnerships with Customers Bank, Surf Air, Ondas and Armada. Governance, data sovereignty and enforced policy are emerging as preconditions for regulated sectors like finance. Investors such as Norwest see room to disrupt ERP and finance software, and they caution that AI should not be trusted with financial calculations. Consolidation and shareholder disputes (Salesforce/Braze, Tiny/Oso Cloud, ZenaTech/Boardwalktech) show the market reshaping.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,484 source documents archived
Query this data → isubstrate.com